TE
CGON icon

Tema ETFs’s CG Oncology CGON Stock Holding History

Tema ETFs’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.88M Buy
68,702
+5,539
+9% +$362K 0.16% 116
2026
Q1 		$4.27M Buy
63,163
+27,106
+75% +$1.54M 0.29% 91
2025
Q4 		$1.5M Buy
36,057
+5,832
+19% +$241K 0.12% 187
2025
Q3 		$1.22M Sell
30,225
-15,856
-34% -$461K 0.1% 225
2025
Q2 		$1.2M Buy
46,081
+17,469
+61% +$421K 0.32% 93
2025
Q1 		$701K Buy
28,612
+20,283
+244% +$571K 0.21% 104
2024
Q4 		$239K Buy
+8,329
New +$285K 0.1% 138

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tema ETFs's CGON Position: Q2 2026 in Review

Tema ETFs increased its CG Oncology (CGON) stake by 8.8% in Q2 2026, buying an estimated $362K and bringing the position to 68,702 shares worth $4.88M. The position accounts for 0.16% of the portfolio, ranked #116.

Tema ETFs first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Tema ETFs held 68,702 shares of CG Oncology worth $4.88M as of Q2 2026.
  • Tema ETFs bought 5,539 CG Oncology shares in Q2 2026, an estimated $362K.
  • CG Oncology made up 0.16% of Tema ETFs's portfolio in Q2 2026, its #116 holding.
  • Tema ETFs first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.